LOGIN
Platelet-rich vs. platelet-poor plasma injections as adjuvant therapy in carpal tunnel surgery
May 2020
Platelet-rich vs. platelet-poor plasma injections as adjuvant therapy in carpal tunnel surgery
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Efficacy of platelet-rich plasma as an adjuvant to surgical carpal ligament release: a prospective, randomized controlled clinical trial.
Sci Rep. 2020 Feb 7;10(1):2085.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Fifty patients with carpal tunnel syndrome unresponsive to conservative therapy and scheduled for a open carpal ligament release procedure were randomized to receive an injection of platelet-rich plasma or platelet-poor plasma into the incision site following the completion of surgery. The primary outcome of interest was hand grip strength in the affected hand. Secondary outcomes of interest inclu...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.